Retour
48
Fourchette du Jour
106,10 €
110,91 €
Fourchette 52 Semaines
71,42 €
115,33 €
Volume
315 270
Moyenne 50J / 200J
94,46 €
/
88,84 €
Clôture Précédente
107,86 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 43,4 | 0,4 |
| P/B | 6,4 | 2,9 |
| ROE % | 15,8 | 3,9 |
| Net Margin % | 23,1 | 3,8 |
| Rev Growth 5Y % | 12,8 | 10,0 |
| D/E | 0,5 | 0,2 |
Objectif de Cours des Analystes
Hold
101,50 €
-7.7%
Low: 95,00 €
High: 108,00 €
P/E Prévisionnel
37,4
BPA Prévisionnel
2,89 €
Croissance BPA (est.)
+0,0%
CA Est.
280 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
0,00 €
0,00 € – 0,00 €
|
350 M | 1 |
| FY2028 |
3,35 €
3,34 € – 3,35 €
|
330 M | 3 |
| FY2027 |
3,16 €
2,93 € – 3,28 €
|
300 M | 7 |
Points Clés
Revenue grew 12,75% annually over 5 years — strong growth
Earnings grew 31,10% over the past year
ROE of 15,80% — decent returns on equity
Net margin of 23,13% shows strong profitability
Debt/Equity of 0,47 — conservative balance sheet
Generating 74,47M in free cash flow
Croissance
Revenue Growth (5Y)
12,75%
Revenue (1Y)13,53%
Earnings (1Y)31,10%
FCF Growth (3Y)58,92%
Qualité
Return on Equity
15,80%
ROIC8,80%
Net Margin23,13%
Op. Margin27,21%
Sécurité
Debt / Equity
0,47
Current Ratio12,89
Interest Coverage13,10
Valorisation
P/E Ratio
43,40
P/B Ratio6,37
EV/EBITDA39,21
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13,53% | Revenue Growth (3Y) | 13,58% |
| Earnings Growth (1Y) | 31,10% | Earnings Growth (3Y) | 38,48% |
| Revenue Growth (5Y) | 12,75% | Earnings Growth (5Y) | 21,03% |
| Profitability | |||
| Revenue (TTM) | 249,60M | Net Income (TTM) | 57,73M |
| ROE | 15,80% | ROA | 9,38% |
| Gross Margin | 71,53% | Operating Margin | 27,21% |
| Net Margin | 23,13% | Free Cash Flow (TTM) | 74,47M |
| ROIC | 8,80% | FCF Growth (3Y) | 58,92% |
| Safety | |||
| Debt / Equity | 0,47 | Current Ratio | 12,89 |
| Interest Coverage | 13,10 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 43,40 | P/B Ratio | 6,37 |
| P/S Ratio | 10,04 | PEG Ratio | 1,06 |
| EV/EBITDA | 39,21 | Dividend Yield | 0,01% |
| Market Cap | 2,51B | Enterprise Value | 2,66B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 249,60M | 219,86M | 193,48M | 161,65M | 154,42M |
| Net Income | 57,73M | 44,04M | 30,11M | 20,64M | 26,91M |
| EPS (Diluted) | 2,52 | 1,93 | 1,34 | 0,93 | 1,25 |
| Gross Profit | 178,54M | 150,90M | 127,05M | 104,90M | 101,38M |
| Operating Income | 67,91M | 52,26M | 36,71M | 26,83M | 36,43M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 615,69M | 551,82M | 346,78M | 310,48M | 292,80M |
| Total Liabilities | 222,17M | 214,53M | 48,88M | 42,28M | 38,65M |
| Shareholders' Equity | 393,52M | 337,29M | 297,90M | 268,20M | 254,15M |
| Total Debt | 185,59M | 185,69M | 19,10M | 16,60M | 15,94M |
| Cash & Equivalents | 28,24M | 25,61M | 24,27M | 19,13M | 13,86M |
| Current Assets | 468,23M | 402,19M | 194,60M | 161,73M | 139,88M |
| Current Liabilities | 36,32M | 30,61M | 29,88M | 25,33M | 21,81M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Balanced Risk
#63 of 151
Activité Récente
Sorti
Cash Flow Compounder
Mar 25, 2026
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Balanced Risk
Mar 24, 2026